98%
921
2 minutes
20
We aimed to validate and evaluate a RapidPlan model for left-sided breast cancer patients receiving hypofractionated PM-RNI. This study included 89 patients with left-sided breast cancer who were enrolled in a clinical trial and received PM-RNI using IMRT. A RapidPlan KBP model was developed using 40 clinical IMRT plans treated at Institution A. The performance of the KBP model was assessed through internal validation and external validations at Institution A (n = 40) and Institution B (n = 9) by comparing the dosimetric indices and treatment efficiency between the initial plans and the re-optimized KBP plans. The KBP model's benefit for planners with different experience levels was evaluated by comparing the quality of non-KBP and KBP plans created by beginner, junior, and senior planners for 10 cases. With comparable target coverage, the KBP plans showed superior normal tissue sparing than the initial plans. On average, the mean heart dose was significantly reduced in the internal validation (p < 0.001), external validation at Institution A (p < 0.001), and increased in the validation at Institution B (but not significantly). In terms of dose conformality, KBP plans achieved a notable improvement in CI during the external validation at Institution A (p = 0.006). Additionally, treatment efficiency was improved by the KBP model for all validation datasets, with a reduction of 2.8% to 8.8% in treatment time. The beginner planners benefit most from the KBP model, which improved plan quality by reducing the mean heart dose by 13.67 cGy (p = 0.020). The RapidPlan model for left-sided breast cancer receiving hypofractionated PM-RNI effectively spares organs and increases IMRT treatment efficiency. We also demonstrated that RapidPlan helps transfer planning skills from senior planners to beginner planners, thus improving the consistency of complex IMRT plans.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.meddos.2025.06.001 | DOI Listing |
Rep Pract Oncol Radiother
August 2025
Hiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
Background: This study aimed to compare the treatment plan between free breathing (FB) and deep inspiration breath-hold (DIBH) in patients with left-sided breast cancer. We aimed to investigate the dose to the heart and left lung.
Materials And Methods: Fifty-five patients with left-sided breast cancer treated with three-dimensional conformal radiotherapy were retrospectively compared with those planned with FB and DIBH in terms of doses to the heart and left lung.
J Appl Clin Med Phys
September 2025
Department of Radiation Oncology, the First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.
Purpose: This study aimed to comprehensively compare the dosimetric characteristics of three different radiotherapy techniques-hybrid intensity-modulated radiotherapy (hy-IMRT), tangential volumetric-modulated arc therapy (t-VMAT), and continuous volumetric-modulated arc therapy (c-VMAT)-used after breast-conserving surgery for left-sided breast cancer in the target area and organs at risk (OARs) after breast-conserving surgery for left-sided breast cancer. This evaluation aims to provide a solid basis for individualized radiotherapy planning in clinical practice.
Methods: Twenty female patients who underwent breast-conserving surgery for left-sided breast cancer were retrospectively selected.
Front Oncol
August 2025
Institute of Medical Imaging and Artificial Intelligence of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Radiotherapy remains essential in breast cancer management, yet its long-term cardiotoxicity, driven primarily by radiation-induced myocardial fibrosis, threatens survivorship, particularly in left-sided tumors. Surgical refinements, including breast-conserving surgery with sentinel lymph node biopsy and total mastectomy, effectively reduce radiation fields and cardiac exposure. Intraoperative radiotherapy with lead shielding markedly lowers left anterior descending artery dose from 5.
View Article and Find Full Text PDFPlast Reconstr Surg Glob Open
August 2025
Department of Anatomy, Jagiellonian University Medical College, Kraków, Poland.
Poland syndrome (PS) is a congenital anomaly characterized by unilateral hypoplasia or absence of the pectoralis major muscle, often associated with breast asymmetry. Achieving symmetry while preserving the contralateral breast remains a challenge in reconstruction. We present a case of a 19-year-old woman with left-sided PS, a fully developed right breast, and limited autologous soft tissue (body mass index 19.
View Article and Find Full Text PDFBreast Cancer
August 2025
Medical Physics and Radiation Measurements Laboratory, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
Background: Radiodermatitis is the predominant acute toxicity in locally advanced breast cancer (BC) radiotherapy. Early-onset radiodermatitis substantially increases the risk of high-grade injury and potential treatment interruption. This study aimed to identify risk factors for early-onset radiodermatitis by analyzing patient characteristics and dose-distribution profiles from step-and-shoot intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT).
View Article and Find Full Text PDF